ONESOURCE.NS Profit & Loss

Onesource Specialty Pharma Ltd.

Profit & Loss · 2 years on file (FY2024-25 to FY2025-26) · fetched 2026-08-23 23:41

Line item	FY2024-25	FY2025-26	Source (XBRL element)
Revenue from Operations	₹14.45 Bn	₹14.22 Bn	RevenueFromOperations
Gross Revenue (incl. inter-segment)	N/A	N/A	SegmentRevenueFromOperations
Other Income	₹0.17 Bn	₹0.15 Bn	OtherIncome
Total Income	₹14.62 Bn	₹14.37 Bn	Income
Cost of Materials Consumed	₹3.28 Bn	₹4.37 Bn	CostOfMaterialsConsumed
Purchases of Stock-in-Trade	₹0.30 Bn	₹0.00 Bn	PurchasesOfStockInTrade
Changes in Inventories	₹0.77 Bn	₹0.08 Bn	ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense	₹2.15 Bn	₹2.42 Bn	EmployeeBenefitExpense
Finance Costs	₹1.66 Bn	₹1.22 Bn	FinanceCosts
Depreciation and Amortisation	₹2.74 Bn	₹2.79 Bn	DepreciationDepletionAndAmortisationExpense
Other Expenses	₹3.28 Bn	₹4.30 Bn	OtherExpenses
Total Expenses	₹14.19 Bn	₹15.19 Bn	Expenses
Profit Before Exceptional Items and Tax	₹0.44 Bn	₹-0.82 Bn	ProfitBeforeExceptionalItemsAndTax
Exceptional Items	₹-1.11 Bn	₹-0.10 Bn	ExceptionalItemsBeforeTax
Profit Before Tax	₹-0.67 Bn	₹-0.92 Bn	ProfitBeforeTax
Tax Expense	₹-0.50 Bn	₹-0.18 Bn	TaxExpense
Net Profit (incl. minority interest)	₹-0.18 Bn	₹-0.74 Bn	ProfitLossForPeriod
Net Profit (to shareholders)	N/A	₹-0.74 Bn	ProfitOrLossAttributableToOwnersOfParent
Basic EPS	₹-1.63	₹-6.44	BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS	₹-1.63	₹-6.44	DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from ONESOURCE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).